# Neurocrine Biosciences Inc: filings

NBIX · Nasdaq · CIK 914475 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nbix.md) · [Financials](/companies/nbix/financials.md) · [Filings](/companies/nbix/filings.md) · [Insiders](/companies/nbix/insiders.md)

## Reports and events: 286 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 961, 8-K 191, 144 170, SC 13G/A 80, 10-Q 53, 3 24, 4/A 22, CT ORDER 20, 10-K 18, DEF 14A 18, S-8 17, SC 13G 16, S-8 POS 13, 424B5 9, DEFA14A 9, UPLOAD 9, CORRESP 7, ARS 4, 3/A 3, 424B3 3, EFFECT 3, S-3 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, SC TO-C 3, SC TO-T/A 3, 8-K/A 2, FWP 2, S-3ASR 2, SC 13D 2, 10-K/A 1, PRE 14A 1, SC 13D/A 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 16:20 ET | [8-K](/filings/0000914475-26-000045.md) | 5.02 Departure or appointment of officers or directors | 0000914475-26-000045 |
| 2026-07-31 | 16:05 ET | [8-K/A](/filings/0001193125-26-328470.md) | 9.01 Financial statements and exhibits | 0001193125-26-328470 |
| 2026-07-31 | 21:22 ET | [10-Q](/filings/0000914475-26-000037.md) | Quarterly report, period 2026-06-30 | 0000914475-26-000037 |
| 2026-07-30 | 16:02 ET | [8-K](/filings/0000914475-26-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-26-000035 |
| 2026-05-28 | 16:01 ET | [8-K](/filings/0000914475-26-000029.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000914475-26-000029 |
| 2026-05-18 | 09:04 ET | [8-K](/filings/0001193125-26-228013.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-228013 |
| 2026-05-05 | 16:02 ET | [10-Q](/filings/0000914475-26-000026.md) | Quarterly report, period 2026-03-31 | 0000914475-26-000026 |
| 2026-05-05 | 16:02 ET | [8-K](/filings/0000914475-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-26-000025 |
| 2026-04-15 | 16:15 ET | [DEF 14A](/filings/0000914475-26-000015.md) | Proxy statement, period 2026-04-15 | 0000914475-26-000015 |
| 2026-04-06 | 07:35 ET | [8-K](/filings/0001193125-26-142904.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-142904 |
| 2026-02-11 | 16:03 ET | [10-K](/filings/0000914475-26-000007.md) | Annual report, period 2025-12-31 | 0000914475-26-000007 |
| 2026-02-11 | 16:02 ET | [8-K](/filings/0000914475-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-26-000006 |
| 2025-11-24 | 16:02 ET | [8-K](/filings/0000914475-25-000186.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000914475-25-000186 |
| 2025-10-28 | 16:03 ET | [10-Q](/filings/0000914475-25-000181.md) | Quarterly report, period 2025-09-30 | 0000914475-25-000181 |
| 2025-10-28 | 16:02 ET | [8-K](/filings/0000914475-25-000180.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000180 |
| 2025-07-30 | 16:04 ET | [10-Q](/filings/0000914475-25-000158.md) | Quarterly report, period 2025-06-30 | 0000914475-25-000158 |
| 2025-07-30 | 16:02 ET | [8-K](/filings/0000914475-25-000157.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000157 |
| 2025-05-30 | 16:05 ET | [8-K](/filings/0000914475-25-000139.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000914475-25-000139 |
| 2025-05-22 | 16:03 ET | [8-K](/filings/0000914475-25-000120.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000914475-25-000120 |
| 2025-05-05 | 16:03 ET | [10-Q](/filings/0000914475-25-000100.md) | Quarterly report, period 2025-03-31 | 0000914475-25-000100 |
| 2025-05-05 | 16:02 ET | [8-K](/filings/0000914475-25-000099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000099 |
| 2025-04-09 | 16:04 ET | [DEF 14A](/filings/0000914475-25-000091.md) | Proxy statement, period 2025-04-09 | 0000914475-25-000091 |
| 2025-04-04 | 08:02 ET | [8-K](/filings/0000914475-25-000081.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914475-25-000081 |
| 2025-02-10 | 16:51 ET | [10-K](/filings/0000914475-25-000037.md) | Annual report, period 2024-12-31 | 0000914475-25-000037 |
| 2025-02-06 | 16:04 ET | [8-K](/filings/0000914475-25-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000034 |
| 2025-01-27 | 16:12 ET | [8-K](/filings/0000914475-25-000006.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914475-25-000006 |
| 2024-12-20 | 08:06 ET | [8-K](/filings/0000914475-24-000229.md) | 8.01 Other events | 0000914475-24-000229 |
| 2024-11-01 | 08:31 ET | [8-K](/filings/0000914475-24-000214.md) | 8.01 Other events | 0000914475-24-000214 |
| 2024-10-30 | 07:04 ET | [10-Q](/filings/0000914475-24-000211.md) | Quarterly report, period 2024-09-30 | 0000914475-24-000211 |
| 2024-10-30 | 07:02 ET | [8-K](/filings/0000914475-24-000210.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000210 |
| 2024-10-11 | 16:02 ET | [8-K](/filings/0000914475-24-000206.md) | 5.02 Departure or appointment of officers or directors | 0000914475-24-000206 |
| 2024-08-28 | 07:00 ET | [8-K](/filings/0000914475-24-000199.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000914475-24-000199 |
| 2024-08-01 | 07:04 ET | [10-Q](/filings/0000914475-24-000181.md) | Quarterly report, period 2024-06-30 | 0000914475-24-000181 |
| 2024-08-01 | 07:03 ET | [8-K](/filings/0000914475-24-000180.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000180 |
| 2024-05-28 | 16:18 ET | [8-K](/filings/0001193125-24-148107.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-148107 |
| 2024-05-23 | 16:01 ET | [8-K](/filings/0000914475-24-000140.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000914475-24-000140 |
| 2024-05-01 | 07:03 ET | [10-Q](/filings/0000914475-24-000117.md) | Quarterly report, period 2024-03-31 | 0000914475-24-000117 |
| 2024-05-01 | 07:01 ET | [8-K](/filings/0000914475-24-000116.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000116 |
| 2024-04-10 | 16:07 ET | [DEF 14A](/filings/0000914475-24-000106.md) | Proxy statement, period 2024-05-22 | 0000914475-24-000106 |
| 2024-02-09 | 17:29 ET | [10-K](/filings/0000914475-24-000054.md) | Annual report, period 2023-12-31 | 0000914475-24-000054 |
| 2024-02-07 | 07:00 ET | [8-K](/filings/0000914475-24-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000033 |
| 2023-11-13 | 07:01 ET | [8-K](/filings/0000914475-23-000078.md) | 8.01 Other events | 0000914475-23-000078 |
| 2023-11-09 | 17:03 ET | [8-K](/filings/0000914475-23-000075.md) | 8.01 Other events | 0000914475-23-000075 |
| 2023-10-31 | 07:02 ET | [10-Q](/filings/0000914475-23-000073.md) | Quarterly report, period 2023-09-30 | 0000914475-23-000073 |
| 2023-10-31 | 07:01 ET | [8-K](/filings/0000914475-23-000072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-23-000072 |
| 2023-10-06 | 09:00 ET | [8-K](/filings/0000914475-23-000067.md) | 8.01 Other events | 0000914475-23-000067 |
| 2023-10-05 | 07:02 ET | [8-K](/filings/0000914475-23-000065.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000914475-23-000065 |
| 2023-09-12 | 07:31 ET | [8-K](/filings/0000914475-23-000062.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000914475-23-000062 |
| 2023-08-01 | 07:03 ET | [10-Q](/filings/0000914475-23-000057.md) | Quarterly report, period 2023-06-30 | 0000914475-23-000057 |
| 2023-08-01 | 07:02 ET | [8-K](/filings/0000914475-23-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-23-000056 |

Page 1 of 6. [Older](/companies/nbix/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:30 ET. No prices; not investment advice.